J&J Vaccine Pause Disrupts an Already-Slow Rollout to Minorities (2)

April 15, 2021, 2:43 AM

The U.S. vaccination drive has failed to equitably reach people of all races, and the pause on the Johnson & Johnson Covid vaccine is halting key efforts to jab hard-to-reach minority populations.

The J&J shot only makes up about 4% of the more than 189 million doses administered. But because it doesn’t require expensive refrigeration and is only one dose, it’s the vaccine of choice for programs aimed at inoculating people who are homebound, homeless, and whose jobs make it hard to schedule multiple appointments. These are groups disproportionately made up of the minority populations already lagging in doses.

Tuesday’s call from U.S. health officials for a...

To read the full article log in.

Learn more about a Bloomberg Law subscription.